Klingenstein Fields & CO LP Quest Diagnostics Inc Transaction History
Klingenstein Fields & CO LP
- $2.48 Billion
- Q3 2024
A detailed history of Klingenstein Fields & CO LP transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 4,000 shares of DGX stock, worth $548,360. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$548,360
Previous $547,000
0.18%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding DGX
# of Institutions
924Shares Held
95.1MCall Options Held
361KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA14MShares$1.92 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
State Street Corp Boston, MA5.26MShares$722 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$528 Million0.07% of portfolio
-
Victory Capital Management Inc3.46MShares$475 Million0.48% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...